ImmunoGen, Inc.
Camptothecin derivatives

Last updated:

Abstract:

Disclosed herein are novel cytotoxic compounds, and cytotoxic conjugates comprising these cytotoxic compounds and cell-binding agents. More specifically, this disclosure relates to novel camptothecin derivatives thereof, intermediates thereof, conjugates thereof, and pharmaceutically acceptable salts thereof, which are useful as medicaments, in particular as anti-proliferative agents (anticancer agents).

Status:
Grant
Type:

Utility

Filling date:

25 Sep 2020

Issue date:

25 Jan 2022